PYC Therapeutics Limited
Status: Publicly traded
Direct answer
PYC Therapeutics Limited is publicly traded on ASX under the ticker PYC.AX.
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program, which is in Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for treating blinding eye disease named Autosomal Dominant Optic Atrophy, which is in...
Can you invest in PYC Therapeutics Limited?
Yes. PYC Therapeutics Limited trades publicly on ASX as PYC.AX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for PYC Therapeutics Limited
Detailed equity research is provided by MarketSnap.